Tuesday, October 20, 2026 from 8:30 a.m. to 10:00 a.m. MDT at Salt Palace Convention Center - Ballroom I
Available for 1.50 hours of CPE creditActivity Number: 0217-0000-26-155-L01-PActivity Type: A Knowledge-Based ActivityThe Endocrine and Metabolism PRN Education Committee presents an educational session focused on the integration of continuous subcutaneous insulin infusion therapy into primary care practice for adults with type 1 and type 2 diabetes. The session will serve as a practical, comprehensive guide to understanding continuous subcutaneous insulin infusion technology and implementing these systems in clinical practice. Specific topics will include (1) understanding continuous subcutaneous insulin infusion therapy by reviewing available continuous subcutaneous insulin infusion systems and summarizing key clinical trial and real-world evidence; and (2) practical implementation strategies for primary care by discussing approaches for integrating continuous subcutaneous insulin infusion data into clinical workflows and outlining best practices for medication management and therapy adjustments in continuous subcutaneous insulin infusion users. Each presentation will be approximately 35 minutes in length, followed by a 20-minute panel session. The target audience for this session is pharmacists, residents, fellows, and students with an interest in enhancing their knowledge of diabetes technology and continuous subcutaneous insulin infusion therapy for diverse patient populations. The primary purpose of this session will be to educate participants on the evidence supporting continuous subcutaneous insulin infusion therapy and provide practical tools for safely and effectively managing these technologies in primary care settings, contributing to improved glycemic outcomes for people with diabetes.
Learning Objectives1. Describe the key features and functions of currently available continuous subcutaneous insulin infusion systems for adults with diabetes.
2. Summarize clinical trial and real-world evidence on glycemic outcomes associated with continuous subcutaneous insulin infusion therapy.
3. Explain approaches to incorporating continuous subcutaneous insulin infusion data into primary care clinic workflows.
4. Outline best practices for medication management and therapy adjustments in patients using continuous subcutaneous insulin infusion in primary care.
5. Discuss real-world challenges and solutions related to implementing continuous subcutaneous insulin infusion therapy in the primary care setting.
 | | Moderator: | Lauren Cunningham, Pharm.D., BCACP, CDCES | | Clinical Assistant Professor Assistant Director, PGY2 Ambulatory Care Residency Program Department of Pharmacy Practice University of Illinois Chicago Retzky College of Pharmacy Ambulatory Care Clinical Pharmacist, Family Medicine University of Illinois Hospital and Health Sciences System | | View Biography |
|
Breaking Down the Basics of Continuous Subcutaneous Insulin Infusion Therapy: Devices and Glycemic Outcomes8:30 a.m. to 9:05 a.m. | | Speaker: | Jordin Millward, Pharm.D., MPH, BCPS, CDCES | | Clinical Assistant Professor Idaho State University L.S. Skaggs College of Pharmacy Pocatello, Idaho
|
|
|
Primed for Practice: Continuous Subcutaneous Insulin Infusion Workflows and Medication Therapy Adjustments9:05 a.m. to 9:40 a.m. |
Facilitated Q&A Panel with All Speakers9:40 a.m. to 10:00 a.m. |